← Evidence map

ArticleDiagnostics (Basel, Switzerland)2026

Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance.

Viktoria Schütz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance. | OpenQuestion